Global Premature Rupture of Membranes (PROM) Testing Market Growth (Status and Outlook) 2024-2030

Global Premature Rupture of Membranes (PROM) Testing Market Growth (Status and Outlook) 2024-2030

The premature rupture of membranes (PROM) is a condition that occurs in pregnancy. It is defined as the breakage of the amniotic sac, which generally takes place one or two hours before the onset of contractions or labor. The early breakage of the membrane, i.e. before 37 weeks of gestation, can lead to inevitable abortion. Additionally, if the rupture of the amniotic sac resulting in fluid leakage is not detected on time, infections or Others complications many occur in the fetus or the mOthers. Leakage or a sudden discharge of fluid from the vagina is the only symptom of PROM. The exact cause of PROM is largely unknown. However, researchers believe that bacterial production in the lower genital tract that travels to the membrane can lead to a leak.

The global Premature Rupture of Membranes (PROM) Testing market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

LPI (LP Information)' newest research report, the “Premature Rupture of Membranes (PROM) Testing Industry Forecast” looks at past sales and reviews total world Premature Rupture of Membranes (PROM) Testing sales in 2023, providing a comprehensive analysis by region and market sector of projected Premature Rupture of Membranes (PROM) Testing sales for 2024 through 2030. With Premature Rupture of Membranes (PROM) Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Premature Rupture of Membranes (PROM) Testing industry.

This Insight Report provides a comprehensive analysis of the global Premature Rupture of Membranes (PROM) Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Premature Rupture of Membranes (PROM) Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Premature Rupture of Membranes (PROM) Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Premature Rupture of Membranes (PROM) Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Premature Rupture of Membranes (PROM) Testing.

Rise in the incidence of pre- and post-natal complications is anticipated to drive the global premature rupture of membranes testing market.

This report presents a comprehensive overview, market shares, and growth opportunities of Premature Rupture of Membranes (PROM) Testing market by product type, application, key players and key regions and countries.

Segmentation by type
Nitrazine/pH Test
Ferning Test
Amnisure Test
Others

Segmentation by application
Hospitals
Clinics
Diagnostic Laboratories
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Qiagen
Medix Biochemica
Hologic
Sera Prognostics
NX Prenatal
Laboratorios Rubio
IQ Products

Please note: The report will take approximately 2 business days to prepare and deliver.